Sun, Sep 21, 2014, 10:30 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • buyoutmoney175 buyoutmoney175 Mar 2, 2013 8:48 AM Flag

    Pssst

    our about to see the moon (PPS) large buys were made on friday ...news is coming (GOOD)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 16.45-18.00 Plenary session 9: Drugs targeting the RAS/RAF/MEK pathway
      Chairpersons: Lee Ellis, Houston, TX, USA; Hilary Calvert, London, UK
      Educational introduction: The RAS/RAF/MEK pathway in cancer
      Ji Luo, National Cancer Institute, Bethesda, MD, USA
      Targeting RAF kinases in BRAF and KRAS mutant cancers
      Ji Luo, National Cancer Institute, Bethesda, MD, USA
      The evaluation of selumetinib a MEK-inhibitor with and without the addition of erlotinib in KRAS mutated Non-Small Cell Lung Cancer
      Corey A. Carter, National Cancer Institute, Bethesda, MD, USA
      Dual combinations involving MEK inhibition
      Anthony Tolcher, START, San Antonio, TX, USA
      , lookfor more accumulation ARRy is about to sky rocket

 
ARRY
3.76-0.03(-0.79%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.